Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate

David Hager, Arjang Djamali, Bruce Kaplan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter serves as a starting point for clinicians and researchers providing the necessary background as well as future directions and applications of the available pharmacodynamic studies in therapeutic drug monitoring. A brief history of mycophenolate and the current understanding of its multiple mechanisms of action are included, as are a review of its preclinical and clinical data. Areas for additional necessary research are described.

Original languageEnglish (US)
Title of host publicationImmunotherapy in Transplantation: Principles and Practice
PublisherWiley-Blackwell
Pages182-196
Number of pages15
ISBN (Print)9781405182713
DOIs
StatePublished - Apr 19 2012
Externally publishedYes

Fingerprint

Drug Monitoring
Pharmacokinetics
Research Personnel
Research
Direction compound

Keywords

  • Drug interactions
  • Graft rejection prevention and control
  • IMP dehydrogenase antagonists and inhibitors
  • Mycophenolic acid
  • Pharmacodynamics
  • Pharmacogenomics
  • Pharmacokinetics
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hager, D., Djamali, A., & Kaplan, B. (2012). Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate. In Immunotherapy in Transplantation: Principles and Practice (pp. 182-196). Wiley-Blackwell. https://doi.org/10.1002/9781444355628.ch14

Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate. / Hager, David; Djamali, Arjang; Kaplan, Bruce.

Immunotherapy in Transplantation: Principles and Practice. Wiley-Blackwell, 2012. p. 182-196.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hager, D, Djamali, A & Kaplan, B 2012, Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate. in Immunotherapy in Transplantation: Principles and Practice. Wiley-Blackwell, pp. 182-196. https://doi.org/10.1002/9781444355628.ch14
Hager D, Djamali A, Kaplan B. Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate. In Immunotherapy in Transplantation: Principles and Practice. Wiley-Blackwell. 2012. p. 182-196 https://doi.org/10.1002/9781444355628.ch14
Hager, David ; Djamali, Arjang ; Kaplan, Bruce. / Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate. Immunotherapy in Transplantation: Principles and Practice. Wiley-Blackwell, 2012. pp. 182-196
@inbook{0b9d05d4604449a4920f67aa742c6692,
title = "Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate",
abstract = "This chapter serves as a starting point for clinicians and researchers providing the necessary background as well as future directions and applications of the available pharmacodynamic studies in therapeutic drug monitoring. A brief history of mycophenolate and the current understanding of its multiple mechanisms of action are included, as are a review of its preclinical and clinical data. Areas for additional necessary research are described.",
keywords = "Drug interactions, Graft rejection prevention and control, IMP dehydrogenase antagonists and inhibitors, Mycophenolic acid, Pharmacodynamics, Pharmacogenomics, Pharmacokinetics, Therapeutic drug monitoring",
author = "David Hager and Arjang Djamali and Bruce Kaplan",
year = "2012",
month = "4",
day = "19",
doi = "10.1002/9781444355628.ch14",
language = "English (US)",
isbn = "9781405182713",
pages = "182--196",
booktitle = "Immunotherapy in Transplantation: Principles and Practice",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate

AU - Hager, David

AU - Djamali, Arjang

AU - Kaplan, Bruce

PY - 2012/4/19

Y1 - 2012/4/19

N2 - This chapter serves as a starting point for clinicians and researchers providing the necessary background as well as future directions and applications of the available pharmacodynamic studies in therapeutic drug monitoring. A brief history of mycophenolate and the current understanding of its multiple mechanisms of action are included, as are a review of its preclinical and clinical data. Areas for additional necessary research are described.

AB - This chapter serves as a starting point for clinicians and researchers providing the necessary background as well as future directions and applications of the available pharmacodynamic studies in therapeutic drug monitoring. A brief history of mycophenolate and the current understanding of its multiple mechanisms of action are included, as are a review of its preclinical and clinical data. Areas for additional necessary research are described.

KW - Drug interactions

KW - Graft rejection prevention and control

KW - IMP dehydrogenase antagonists and inhibitors

KW - Mycophenolic acid

KW - Pharmacodynamics

KW - Pharmacogenomics

KW - Pharmacokinetics

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=84885753202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885753202&partnerID=8YFLogxK

U2 - 10.1002/9781444355628.ch14

DO - 10.1002/9781444355628.ch14

M3 - Chapter

AN - SCOPUS:84885753202

SN - 9781405182713

SP - 182

EP - 196

BT - Immunotherapy in Transplantation: Principles and Practice

PB - Wiley-Blackwell

ER -